Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Embryology Laboratory, |
RCV000008509 | SCV000680456 | pathogenic | Char syndrome | 2017-09-08 | criteria provided, single submitter | research | This variant was identified in an Australian family of Caucasian descent. This novel missense mutation (with respect to ExAC) segregates completely with disease in 7 individuals across 3 generations. All carriers of this variant exhibit suble characteristic CHAR syndrome features, except one individual who appears asymptomatic, suggesting incomplete penetrance of this variant. |
Gene |
RCV002508186 | SCV002818057 | likely pathogenic | not provided | 2022-12-27 | criteria provided, single submitter | clinical testing | Published functional studies suggest a damaging effect; specifically, expression studies indicate R274Q results in reduced transactivation function via decreased DNA binding capacity (Zhao et al., 2001); Not observed in large population cohorts (gnomAD); Known as R274Q by alternate nomenclature; This variant is associated with the following publications: (PMID: 29555671, 11505339, 25500235) |
OMIM | RCV000008509 | SCV000028717 | pathogenic | Char syndrome | 2001-10-01 | no assertion criteria provided | literature only | |
Gene |
RCV000008509 | SCV000040998 | not provided | Char syndrome | no assertion provided | literature only |